Jeffrey M. Leiden

VERTEX PHARMACEUTICALS

Chairman, President & CEO

Overview

Jeffrey M. Leiden received an average compensation of $18,411,882 at VERTEX PHARMACEUTICALS from 2011 to 2017.

Annual data

2017

Non-Equity Incentive Plan$3,463,200
Option Awards$3,700,877
Salary$1,300,000
Stock Awards$8,750,114
Other$13,110
Total$17,227,301

In 2017, Jeffrey M. Leiden earned a total compensation of $17,227,301 as Chairman, President & CEO at VERTEX PHARMACEUTICALS INC.

Leiden received $8,750,114 in stock awards, which accounts for 50.79% of total compensation.

Leiden also received $3,463,200 in non-equity incentive plan, $3,700,877 in option awards, $1,300,000 in salary and $13,110 in other compensation.